Abstract: In an embodiment, for any structural change that is made to a relational database, a corresponding change is also made to the multidimensional database. In an embodiment, the system determines that a particular structure is not implemented on the multidimensional database system. Based on metadata that defines the structure that is supposed to exist in the multidimensional database, the appropriate structure is created.

Abstract: The invention concerns an engine assembly (1) comprising a turbocharged engine with at least one cylinder having first and second outlet passages, the first passage being connected to a first manifold (5) while the second passage is connected to a second manifold (7) of an exhaust system comprising a first duct (4) extending from the first manifold (5) and a second duct (6) extending from the second manifold (7). The turbine (2) is provided with a wheel housed in a main pressure-relieving passage, the first duct (4) opening into the main passage. The first outlet passage is provided with means (20) for actively closing during the exhaust phase of the engine and the second duct (6) opens into at least one internal branching portion (8) of the turbine (2), bypassing the main pressure-relieving passage.

Abstract: A system for naming a process being monitored that handles a requesting a framework such as a .NET framework. The process may be implemented by a .NET application framework within an IIS web server. The naming system allows for user readable names which are more than just numbers or indexes. The naming system is configured from a single location rather than from multiple locations, making it much easier to configure, change and update.

Abstract: The invention relates to an engine assembly (1) comprising a turbine (2) and an exhaust system removing the gasses from the engine and comprising a first pipe (4) leading from a first manifold (5) and a second discharge pipe (6) leading from a second manifold (7), the turbine (2) comprising a casing (2c) surrounding it and an energy-recovering impeller, the first pipe (4) opening into a main expansion passage housing the impeller. The second pipe (6) opens into at least one bypass portion (8) internal to the casing (2c) and bypassing the main expansion passage, the main expansion passage and said at least one bypass portion (8) meeting at an outlet face (2b) of the casing (2c), the main expansion passage comprising, inside the turbine (2), a valve for regulating the flow of exhaust gas passing through it.

Abstract: In an embodiment, for any structural change that is made to a relational database, a corresponding change is also made to the multidimensional database. In an embodiment, the system determines that a particular structure is not implemented on the multidimensional database system. Based on metadata that defines the structure that is supposed to exist in the multidimensional database, the appropriate structure is created.

Abstract: A system implements code trampolining techniques by generating custom trampoline functions, compiling the functions, and executing the compiled functions directly from a library when the corresponding native function is called. The native functions may be binary functions, such as functions in C++ code, or other languages. A code generator may read a set of functions to be implemented and generate code, such as binary code, for the destination function. In doing so, the code generator may generate code which matches the source function signature. The generated code may then be compiled into a shared library which is loaded by the process being instrumented. When the library is initiated upon subsequent calls for the native function, the trampoline mechanisms will be set up between the source function and the generated destination function to operate seamlessly with matching signatures.

Abstract: A system for naming a process being monitored that handles a requesting a framework such as a .NET framework. The process may be implemented by a .NET application framework within an IIS web server. The naming system allows for user readable names which are more than just numbers or indexes. The naming system is configured from a single location rather than from multiple locations, making it much easier to configure, change and update.

Abstract: A system detects memory leaks in Node.JS applications. The memory leaks are associated with lines of code rather than particular objects. Lines of code associated with a memory leak is identified by object allocation tracking. Object allocation for lines of code is tracked. A heap snapshot may be captured at the same time at which the object allocation occurs. The results of the object allocation are processed, including removal of objects cleaned up by garbage collection. Objects remaining in the object allocation results are then searched for the end heap snapshot. For objects found in the heap snapshot, the corresponding lines of code that generate the objects are reported to administrators the application.

Abstract: A system for naming a process being monitored that handles a requesting a framework such as a .NET framework. The process may be implemented by a .NET application framework within an IIS web server. The naming system allows for user readable names which are more than just numbers or indexes. The naming system is configured from a single location rather than from multiple locations, making it much easier to configure, change and update.

Abstract: Compounds are provided having inter alia good duration of action, high potency and/or convenient dosing regimens including once weekly administration. The compounds are engineered polypeptides which incorporate an albumin binding domain in combination with one or more biologically active polypeptides. Also provided are pharmaceutical compositions and methods of treatment for diseases and disorders including lipodystrophy, dyslipidemia, hyperlipidemia, overweight, obesity, hypothalamic amenorrhea, Alzheimer's disease, leptin deficiency, fatty liver disease or diabetes (including type I and type II). Additional diseases and disorders which can be treated by the compounds and methods described herein include nonalcoholic steatohepatitis (NASH) and nonalcoholic fatty liver disease (NAFLD), metabolic syndrome X and Huntington's Disease.

Abstract: A system for naming a process being monitored that handles a requesting a framework such as a .NET framework. The process may be implemented by a .NET application framework within an IIS web server. The naming system allows for user readable names which are more than just numbers or indexes. The naming system is configured from a single location rather than from multiple locations, making it much easier to configure, change and update.

Abstract: The present invention provides novel Pancreatic Polypeptide Family (“PPF”) polypeptides and methods for their use.

Abstract: In an embodiment, for any structural change that is made to a relational database, a corresponding change is also made to the multidimensional database. In an embodiment, the system determines that a particular structure is not implemented on the multidimensional database system. Based on metadata that defines the structure that is supposed to exist in the multidimensional database, the appropriate structure is created.

Abstract: In an embodiment, for any structural change that is made to a relational database, a corresponding change is also made to the multidimensional database. In an embodiment, the system determines that a particular structure is not implemented on the multidimensional database system. Based on metadata that defines the structure that is supposed to exist in the multidimensional database, the appropriate structure is created.

Abstract: The present invention provides novel Pancreatic Polypeptide Family (“PPF”) polypeptides and methods for their use.

Abstract: Compounds are provided having inter alia good duration of action, high potency and/or convenient dosing regimens including once weekly administration. The compounds are engineered polypeptides which incorporate an albumin binding domain in combination with one or more biologically active polypeptides. Also provided are pharmaceutical compositions and methods of treatment for diseases and disorders including lipodystrophy, dyslipidemia, hyperlipidemia, overweight, obesity, hypothalamic amenorrhea, Alzheimer's disease, leptin deficiency, fatty liver disease or diabetes (including type I and type II). Additional diseases and disorders which can be treated by the compounds and methods described herein include nonalcoholic steatohepatitis (NASH) and nonalcoholic fatty liver disease (NAFLD), metabolic syndrome X and Huntington's Disease.

Abstract: Methods for affecting body composition include the use of amylin agonists, such as pramlintide or davalintide. Total body weight may be reduced, maintained or even increased; however, the body fat is reduced or body fat gain is prevented, while lean body mass is maintained or increased.

Abstract: Methods for affecting body composition include the use of amylin or amylin agonist(s). Total body weight be reduced, maintained or even increased; however, the body fat is reduced or body fat gain is prevented, while lean body mass is maintained or increased.

Abstract: The present invention provides novel Pancreatic Polypeptide Family (“PPF”) polypeptides and methods for their use.

Abstract: Compounds are provided having inter alia good duration of action, high potency and/or convenient dosing regimens including once weekly administration. The compounds are engineered polypeptides which incorporate an albumin binding domain in combination with one or more biologically active polypeptides. Also provided are pharmaceutical compositions and methods of treatment for diseases and disorders including lipodystrophy, dyslipidemia, hyperlipidemia, overweight, obesity, hypothalamic amenorrhea, Alzheimer's disease, leptin deficiency, fatty liver disease or diabetes (including type I and type II). Additional diseases and disorders which can be treated by the compounds and methods described herein include nonalcoholic steatohepatitis (NASH) and nonalcoholic fatty liver disease (NAFLD), metabolic syndrome X and Huntington's Disease.